Synopsys, Inc.

Synopsys, Inc. saw a significant rise in its stock price today, contrasting with the modest gain of the S&P 500. Despite this uptick, the company has faced challenges recently, including a decline over the past week and negative results for nine consecutive quarters, highlighting concerns about its financial health.

Synopsys, Inc. saw a notable increase in its stock performance today, reaching an intraday high. However, the company has struggled with longer-term performance, lagging behind the S&P 500 over the past year and three years. Synopsys has a market capitalization of USD 83,370 million and a price-to-earnings ratio of 53.00.

Synopsys, Inc. faced a notable stock decline today, reaching an intraday low amid a challenging trading session. While the company has shown a year-to-date increase, its performance lags behind the S&P 500. Despite consistent operating profit growth, it has reported negative results for eight consecutive quarters.

Synopsys, Inc. has demonstrated notable stock performance, with significant gains over various time frames. The company maintains a strong market capitalization of USD 83.37 billion and exhibits high management efficiency, reflected in its return on equity and low debt-to-equity ratio. Promoter confidence is also increasing.

Synopsys, Inc. faced a significant decline on February 23, 2026, with its stock reaching an intraday low. The company has struggled recently, underperforming against the S&P 500 and showing negative results for five consecutive quarters, despite maintaining strong long-term fundamentals and a high valuation compared to peers.

Synopsys, Inc. has shown strong recent performance, with a notable increase on December 4, 2025, and a significant rise over the past week. However, the company has faced challenges, reporting negative results for five consecutive quarters and experiencing an annual decline, despite its large market capitalization.

Synopsys, Inc. has seen a significant rise in its stock today, outperforming the S&P 500. Over the past week, the company has improved notably, although its year-to-date performance remains negative. Despite recent gains, Synopsys has faced challenges over the past year, reflecting a decline in stock value.

Synopsys, Inc. has seen a notable increase in its stock performance today, contrasting with a slight decline in the S&P 500. While the company has experienced fluctuations over the past year and year-to-date, it maintains a strong market capitalization and a reasonable price-to-earnings ratio, indicating potential for recovery.

Synopsys, Inc. saw a notable increase in its stock today, outperforming the broader market. Despite recent gains and a strong weekly performance, the company faces challenges with a year-to-date decline and negative results over the past five quarters, indicating ongoing financial difficulties.

Synopsys, Inc. saw a significant increase in its stock price today, contrasting with the S&P 500's modest rise. Despite recent gains, the company has faced challenges, including a notable decline over the past month and year. Its market capitalization stands at USD 115,263 million, with a price-to-earnings ratio of 56.00.

Synopsys, Inc. has recently adjusted its valuation, with a P/E ratio of 56 and a price-to-book value of 7.81. The company shows strong operational efficiency, reflected in a high ROCE of 24.32% and ROE of 13.98%. Despite these metrics, Synopsys has struggled with stock performance this year.

Synopsys, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 56 and a price-to-book value of 7.81. Despite facing challenges with a year-to-date return of -18.94%, the company has demonstrated resilience over three years, although it lags behind the S&P 500 and peers like Microsoft and Salesforce.

Synopsys, Inc. faced a notable stock decline, continuing a trend of negative performance over the past five quarters. The company has seen significant decreases in its stock value over various time frames, underperforming the S&P 500. Financial metrics indicate a premium valuation amid rising raw material costs.

Synopsys, Inc. faced a notable stock decline, reaching an intraday low amid ongoing challenges. The company has reported negative results for five consecutive quarters, with rising raw material costs impacting its financial metrics. Year-to-date, its stock performance has significantly lagged behind the S&P 500.

Synopsys, Inc. has encountered a technical event known as a Death Cross, indicating potential shifts in market sentiment. The company is experiencing bearish indicators across various metrics, including MACD and Bollinger Bands. Over the past year, Synopsys has underperformed compared to the S&P 500, prompting close monitoring of its market position.